7Baggers
 Esperion announces $210M convertible debt financing  MSN Sat, 15 Nov 2025 17:16:45 GMT
 Relative strength of Esperion Therapeutics Inc. in sector analysis  newser.com Thu, 13 Nov 2025 17:42:47 GMT
 Wasatch Ultra Growth Fund Q3 2025 Top Contributors And Detractors  Seeking Alpha Wed, 12 Nov 2025 15:16:00 GMT
 Esperion Therapeutics: Biotech With Limited Upside, Hold  Seeking Alpha Tue, 11 Nov 2025 07:06:28 GMT
 esperion stock: biotech with limited upside, hold (nasdaq:espr)  Seeking Alpha Tue, 11 Nov 2025 07:06:28 GMT
 esperion announces new data from clear outcomes on nexletol  TipRanks Mon, 10 Nov 2025 15:00:10 GMT
 Esperion Announces New Data from CLEAR Outcomes  GlobeNewswire Mon, 10 Nov 2025 13:00:00 GMT
 esperion therapeutics reports strong q3 revenue growth  MSN Sat, 08 Nov 2025 08:36:39 GMT
 esperion therapeutics: q3 earnings snapshot  Connecticut Post Fri, 07 Nov 2025 11:57:29 GMT
 ESPR's Q3 Earnings Lag Estimates, Revenues Rise Y/Y, Stock Down  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 esperion therapeutics reports strong q3 revenue growth  TipRanks Fri, 07 Nov 2025 04:45:18 GMT
 esperion therapeutics (espr) reports q3 loss, tops revenue estimates  sharewise.com Fri, 07 Nov 2025 04:45:05 GMT
 esperion therapeutics reports strong q3 growth amid challenges  TipRanks Fri, 07 Nov 2025 00:59:03 GMT
 Esperion Therapeutics: Q3 Earnings Snapshot  New Haven Register Thu, 06 Nov 2025 15:19:32 GMT
 esperion’s revenue climbs as it eyes long-term market defense  Finimize Thu, 06 Nov 2025 14:04:26 GMT
 esperion q3 revenue up 69% on prescription volumes  MarketScreener Thu, 06 Nov 2025 11:12:45 GMT
 Esperion Therapeutics Reports Strong Q3 Growth Amid Challenges  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Esperion Therapeutics Reports Strong Q3 Revenue Growth  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 esperion therapeutics (espr) reports q3 loss, tops revenue estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 esperion appoints new chief commercial officer  MSN Wed, 05 Nov 2025 11:38:32 GMT
 esperion appoints new chief commercial officer  TipRanks Tue, 04 Nov 2025 14:22:08 GMT
 Esperion Therapeutics Appoints New Chief Commercial Officer  TradingView Tue, 04 Nov 2025 13:55:00 GMT
 published on: 2025-11-03 04:49:46  newser.com Mon, 03 Nov 2025 10:49:46 GMT

Esperion Therapeutics, Inc
(NASDAQ:ESPR) 

ESPR stock logo

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic aci...

Founded: 1998
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends